Deventer Sander van Insider Trading $QURE uniQure N.V.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deventer Sander van.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deventer Sander van. Deventer Sander van is Director in ARGOS THERAPEUTICS INC ($ARGS) and Chief Scientific Officer in uniQure N.V. ($QURE) and Director in uniQure N.V. ($QURE) and EVP, Research & Product Dev. in uniQure N.V. ($QURE) and Director in HOOKIPA Pharma Inc. ($HOOK).
Deventer Sander van in uniQure N.V.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deventer Sander van: EVP, Research & Product Dev., Chief Scientific Officer, Director
Holdings: 61,599 shares
Current Value: $392,386
Latest Transaction: Mar 02 2020
$QURE Market Capitalization: $165.39M
$QURE Previous Close: $6.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Deventer Sander van in uniQure N.V.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARGS, HOOK, QURE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Option Exercise | A | 51.81 | 21,719 | 1,125,261 | 21,719 | |
| Mar 02 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Grant | A | 0.00 | 12,380 | 0 | 61,599 | 49.2 K to 61.6 K (+25.15 %) |
| Jan 31 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Grant | A | 0.00 | 6,092 | 0 | 49,219 | 43.1 K to 49.2 K (+14.13 %) |
| Jan 30 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Sell | S | 62.10 | 923 | 57,318 | 43,127 | 44.1 K to 43.1 K (-2.10 %) |
| Jan 30 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Sell | S | 61.27 | 1,304 | 79,896 | 44,050 | 45.4 K to 44.1 K (-2.88 %) |
| Sep 19 2019 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Grant | A | 0.00 | 15,000 | 0 | 45,354 | 30.4 K to 45.4 K (+49.42 %) |
| Jan 30 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Sell | S | 31.31 | 1,358 | 42,519 | 40,313 | 41.7 K to 40.3 K (-3.26 %) |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 31.71 | 18,325 | 581,086 | 18,325 | |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 10,913 | 0 | 41,571 | 30.7 K to 41.6 K (+35.60 %) |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 5,589 | 0 | 30,658 | 25.1 K to 30.7 K (+22.29 %) |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 31.71 | 18,325 | 581,086 | 18,325 | |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 10,913 | 0 | 41,571 | 30.7 K to 41.6 K (+35.60 %) |
| Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 5,589 | 0 | 30,658 | 25.1 K to 30.7 K (+22.29 %) |
| Jan 31 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Sell | S | 18.53 | 5,985 | 110,902 | 25,069 | 31.1 K to 25.1 K (-19.27 %) |
| Jan 30 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 19.39 | 20,788 | 403,079 | 20,788 | |
| Jan 30 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 7,795 | 0 | 31,054 | 23.3 K to 31.1 K (+33.51 %) |
| Sep 22 2017 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 8.49 | 150,000 | 1,273,500 | 150,000 | |
| Jan 31 2017 | QURE | uniQure N.V. | van Deventer Sander | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
| Jan 31 2017 | QURE | uniQure N.V. | van Deventer Sander | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 |
Page: 1